Cancer Neutron Capture Therapy

Nonfiction, Health & Well Being, Medical, Specialties, Dermatology, Oncology
Cover of the book Cancer Neutron Capture Therapy by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781475795677
Publisher: Springer US Publication: June 29, 2013
Imprint: Springer Language: English
Author:
ISBN: 9781475795677
Publisher: Springer US
Publication: June 29, 2013
Imprint: Springer
Language: English

There are many human cancers which actively synthesize specific characteristic proteins such as melanomas, thyroid cancer and squamous cell carcinoma. Many cancer researchers have of course tried to utilize this specific activity as a key for the selective treatment of cancers. In the past for example, the molecular hybrid compound of DOPA, a substrate of melanin, and nitrogen mustard N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized as Melphalan and used to treat malignant melanoma. A major problem arose though in that it was soon found to be highly suppressive toward bone marrow and quite toxic while not being remarkably effective. Thus, malignant melanoma could not be cured by it. Such failure led us to develop a novel bimodal therapeutic system which includes the use of non-toxic potentially cytocidal chemicals which selectively accumulate within the cancer cells and which are converted by a controllable modality into an actively cytocidal element in situ. We can now non-surgically cure malignant melanoma and glioblastoma with our selective cancer treatment, neutron capture therapy (NCT); as can be found in this volume. Included are 124 papers on the latest breaking developments discussed at the Sixth International Symposium on NCT for Cancer held in Kobe during the late autumn of 1994.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

There are many human cancers which actively synthesize specific characteristic proteins such as melanomas, thyroid cancer and squamous cell carcinoma. Many cancer researchers have of course tried to utilize this specific activity as a key for the selective treatment of cancers. In the past for example, the molecular hybrid compound of DOPA, a substrate of melanin, and nitrogen mustard N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized as Melphalan and used to treat malignant melanoma. A major problem arose though in that it was soon found to be highly suppressive toward bone marrow and quite toxic while not being remarkably effective. Thus, malignant melanoma could not be cured by it. Such failure led us to develop a novel bimodal therapeutic system which includes the use of non-toxic potentially cytocidal chemicals which selectively accumulate within the cancer cells and which are converted by a controllable modality into an actively cytocidal element in situ. We can now non-surgically cure malignant melanoma and glioblastoma with our selective cancer treatment, neutron capture therapy (NCT); as can be found in this volume. Included are 124 papers on the latest breaking developments discussed at the Sixth International Symposium on NCT for Cancer held in Kobe during the late autumn of 1994.

More books from Springer US

Cover of the book mHealth by
Cover of the book The Lerma-Chapala Watershed by
Cover of the book Quantitative Problem Solving Methods in the Airline Industry by
Cover of the book The Power of Profit by
Cover of the book Stress Between Work and Family by
Cover of the book Ethics in Real Estate by
Cover of the book Feedback Control of MEMS to Atoms by
Cover of the book Physiology and Biochemistry of Plant-Pathogen Interactions by
Cover of the book Clinical Neuropsychological Assessment by
Cover of the book Pediatric and Adolescent Osteosarcoma by
Cover of the book The Evolution of Complex Hunter-Gatherers by
Cover of the book Phosphate Fibers by
Cover of the book The Year in Endocrinology 1977 by
Cover of the book Single Family Selective Rehabilitation by
Cover of the book Techniques in Molecular Biology by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy